The REPLICCAR Registry and The Statewide Quality Improvement Initiative

NCT ID: NCT05363696

Last Updated: 2022-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9723 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-08-01

Study Completion Date

2019-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular diseases remain the leading cause of death for the healthcare system and cardiac surgery has an important impact on their resolubility. Healthcare systems in the world have evolved to optimize their clinical records and thus learn from the real world through the interactivity between results, processes, and structure. When the rate of growth of healthcare costs scenario is greater than the one of Gross Domestic Product of countries, there is a considerable challenge to increment the quality of healthcare services and the primordial patient safety, as well as the necessary control and traceability of implantable devices. The association and correlation of patients' demographic and clinically relevant information with the resources required for the care provided for each stratum represent the possibility to adapt, improve and innovate the healthcare programs; This will allow improving the optimization of the therapeutic protocols and the creation of related research areas, aiming to promote more equitable resources allocation, increase access and effectiveness, as well as to ascertain the magnitude of available and used resources and its impact.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

METHODS Extension Cohort study, mandatory, prospective multicenter, in the state of São Paulo and of registry of consecutive cases. Besides the situational diagnostic of the results and comparison between the mean of both registries, there will be the creation of improvement reports for each of the REPLICCAR centers.

Next, quality improvement initiatives will be implemented in each center indicated by the reports.

Sample

* Will be included in a consecutive way all patients that had CABG and heart valve surgery in the participant centers for the defined period;
* Data will be collected, independently of surgical volume, severity status, and social condition among others, in sight of the São Paulo state health department;
* This way, it will be possible to produce a predictive curve to be used in most clinical case scenarios observed in the state of São Paulo;

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary artery bypass grafting (CABG)

Coronary artery bypass grafting surgery procedure

Intervention Type PROCEDURE

Heart valve surgery

Heart valve surgery procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18- 90 years old.
* CABG or heart valve surgery
* Agreement to participate in the study signing informed consent documentation.

Exclusion Criteria

* Re-operation
* Impossibility to access data variables relevant to the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto do Coração do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo

UNKNOWN

Sponsor Role collaborator

Hospital Samaritano Paulista

OTHER

Sponsor Role collaborator

Hospital Israelita Albert Einstein

OTHER

Sponsor Role collaborator

Beneficência Portuguesa de São Paulo

OTHER

Sponsor Role collaborator

Instituto Dante Pazzanese de Cardiologia

OTHER

Sponsor Role collaborator

Hospital das Clinicas da Universidade Estadual de Campinas

UNKNOWN

Sponsor Role collaborator

Hospital de Base de São Jose do Rio Preto

UNKNOWN

Sponsor Role collaborator

Irmandade da Santa Casa de Misericórdia de Marília

UNKNOWN

Sponsor Role collaborator

Irmandade da Santa Casa de Misericórdia de São Paulo

UNKNOWN

Sponsor Role collaborator

Irmandade da Santa Casa de Misericórdia de Piracicaba

UNKNOWN

Sponsor Role collaborator

Hospital São Paulo da Universidade Federal de São Paulo

UNKNOWN

Sponsor Role collaborator

Hospital Pitangueiras do Grupo SOBAM

UNKNOWN

Sponsor Role collaborator

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

UNKNOWN

Sponsor Role collaborator

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Omar AV Mejia, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

USP Heart Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

USP Heart Institute

São Paulo, , Brazil

Site Status

Fabio B Jatene, MD, PhD

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Orlandi BMM, Mejia OAV, Borgomoni GB, Goncharov M, Rocha KN, Bassolli L, Melo de Barros E Silva PG, Nakazone MA, Sousa A, Campagnucci VP, de Sousa Vilarinho KA, Katz M, Tiveron MG, Arrais Dos Santos M, Lisboa LAF, Dallan LAO, Jatene FB; REPLICCAR II Study Group. REPLICCAR II Study: Data quality audit in the Paulista Cardiovascular Surgery Registry. PLoS One. 2020 Jul 10;15(7):e0223343. doi: 10.1371/journal.pone.0223343. eCollection 2020.

Reference Type RESULT
PMID: 32649718 (View on PubMed)

Borgomoni GB, Dias RD, de Barros E Silva PGM, Nakazone MA, de Oliveira MAP, Campagnucci VP, Tiveron MG, Lisboa LAF, Hajjar LA, Zubelli JP, Jatene FB, Mejia OAV; REPLICCAR study group. Incidence of failure-to-rescue after coronary artery bypass grafting: a multicenter observational study from the REPLICCAR II registry in Brazil. Patient Saf Surg. 2025 Feb 11;19(1):6. doi: 10.1186/s13037-024-00417-9.

Reference Type DERIVED
PMID: 39934891 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

450617006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.